Clinical Laserthermia Systems AB (publ) (STO:CLS.B)
1.930
-0.050 (-2.53%)
Jul 24, 2026, 5:29 PM CET
STO:CLS.B Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.87 | 21.55 | 22.51 | 15.33 | 10.45 | 1.71 |
Short-Term Investments | - | - | - | 0 | 0.14 | 29.46 |
Cash & Short-Term Investments | 3.87 | 21.55 | 22.51 | 15.33 | 10.59 | 31.17 |
Cash Growth | -76.09% | -4.27% | 46.80% | 44.80% | -66.03% | 162.53% |
Accounts Receivable | 6.34 | 2.6 | 4.59 | 2.64 | 1.3 | 0.53 |
Other Receivables | 1.72 | 1.63 | 2.18 | 2.14 | 7.1 | 4.96 |
Total Trade Receivables | 8.06 | 4.23 | 6.77 | 4.78 | 8.4 | 5.49 |
Inventory | 11.11 | 12.7 | 8.15 | 6.12 | 3.07 | 4.61 |
Other Current Assets | 0.83 | 0.65 | 0.98 | 0.92 | 2.2 | 1.16 |
Total Current Assets | 23.86 | 39.12 | 38.41 | 27.15 | 24.26 | 42.43 |
Net Property, Plant & Equipment | 19.69 | 14.04 | 13.14 | 3.88 | 1.8 | 1.48 |
Other Intangible Assets | 10.29 | 11.3 | 13.48 | 18.88 | 17.66 | 19.59 |
Other Long-Term Assets | 12.73 | 12.03 | 13.53 | 7.82 | 5.78 | 3.24 |
Total Assets | 66.57 | 76.49 | 78.56 | 57.73 | 49.51 | 66.74 |
Accounts Payable | 15.31 | 5.88 | 6.3 | 9.17 | 5.93 | 4.31 |
Accrued Expenses | 3.88 | 2.65 | 4.84 | 3.18 | 3.43 | 4.78 |
Current Portion of Long-Term Debt | - | - | - | - | - | 0.1 |
Current Portion of Leases | - | 0 | 0.22 | 0.23 | 0 | - |
Other Current Liabilities | 2.88 | 1.48 | 1.52 | 1.39 | 32.28 | 36.26 |
Total Current Liabilities | 22.07 | 10 | 12.87 | 13.97 | 41.64 | 45.45 |
Long-Term Debt | - | - | - | - | 0 | 0.1 |
Long-Term Leases | - | 0 | 0.01 | 0.22 | - | - |
Total Long-Term Liabilities | - | 0 | 0.01 | 0.22 | 0 | 0.1 |
Total Liabilities | 22.07 | 10 | 12.87 | 14.2 | 41.64 | 45.55 |
Common Stock | 71.98 | 71.98 | 46.58 | 15.43 | 12.05 | 6.09 |
Additional Paid-in Capital | - | 9.64 | 39.95 | 9.8 | 66.13 | 339.83 |
Accumulated Other Comprehensive Income | 1.96 | 1.85 | 2.08 | 3.56 | 1.91 | 3.4 |
Retained Earnings | -26.11 | -13.8 | -19.88 | 16.99 | -70.87 | -327.52 |
Total Common Shareholders' Equity | 47.84 | 69.67 | 68.72 | 45.77 | 9.22 | 21.18 |
Minority Interest | -3.34 | -3.19 | -3.04 | -2.24 | -1.35 | -0.61 |
Shareholders' Equity | 44.5 | 66.48 | 65.69 | 43.53 | 7.87 | 21.18 |
Total Liabilities & Equity | 66.57 | 76.49 | 78.56 | 57.73 | 49.51 | 66.74 |
Total Debt | - | 0 | 0.22 | 0.45 | 0 | 0.2 |
Net Cash (Debt) | 3.87 | 21.55 | 22.28 | 14.88 | 10.59 | 30.97 |
Net Cash Growth | -75.75% | -3.30% | 49.78% | 40.51% | -65.81% | 174.73% |
Net Cash Per Share | 0.13 | 0.69 | 0.86 | 0.18 | 0.13 | 107.67 |
Book Value | 47.84 | 69.67 | 68.72 | 45.77 | 9.22 | 21.18 |
Book Value Per Share | 1.61 | 2.24 | 2.66 | 0.55 | 0.11 | 73.66 |
Tangible Book Value | 37.55 | 58.37 | 55.24 | 26.89 | -8.45 | 1.59 |
Tangible Book Value Per Share | 1.26 | 1.87 | 2.14 | 0.32 | -0.10 | 5.54 |